Familial neurogenic tumor syndromes.
Cancer caused more than 0.5 million deaths in the United States in 2000. This estimate includes patients who have a genetic predisposition to neoplastic disease, including brain neoplasms. Familial tumor syndromes are important to identify clinically because family members require high degrees of monitoring and genetic counseling. Study of these individuals and families has led to the discovery of genes that are an intrinsic aspect of cell regulation and will continue to be relevant in defining mechanisms of neoplastic development in brain and other tissues.
Kimmelman
A
A
Mount Sinai-NYU Medical Center and Health Systems, Derald H. Ruttenberg Cancer Center, New York, New York, USA.
Liang
B C
BC
D001478:Basal Cell Nevus Syndrome / Q000175:diagnosis / Q000235:genetics; D006223:Hamartoma Syndrome, Multiple / Q000175:diagnosis / Q000235:genetics; D006801:Humans; D016864:Li-Fraumeni Syndrome / Q000175:diagnosis / Q000235:genetics; D009377:Multiple Endocrine Neoplasia / Q000175:diagnosis / Q000235:genetics; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis* / Q000235:genetics*; D009456:Neurofibromatosis 1 / Q000175:diagnosis / Q000235:genetics; D016518:Neurofibromatosis 2 / Q000175:diagnosis / Q000235:genetics; D014402:Tuberous Sclerosis / Q000175:diagnosis / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000175:diagnosis / Q000235:genetics